These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3131837

  • 41. Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia.
    Chakrabarty S, Thomas P, Sheridan DJ.
    Eur Heart J; 1991 May; 12(5):583-9. PubMed ID: 1874258
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
    Ko FN, Yu SM, Chen IS, Ishii H, Chang YL, Huang TF, Teng CM.
    Biochim Biophys Acta; 1993 Jan 17; 1175(2):225-31. PubMed ID: 8380343
    [Abstract] [Full Text] [Related]

  • 47. Effects of ethanol on human platelets stimulated with platelet-activating factor, a biologically active ether phospholipid.
    Baker RC, Fish HT, Fitzpatrick FA.
    Alcohol Clin Exp Res; 1989 Dec 17; 13(6):824-8. PubMed ID: 2557776
    [Abstract] [Full Text] [Related]

  • 48. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P, Giordani A, Menichincheri M, Pillan A, Pinciroli V, Rossi A, Tonani R, Volpi D, Tamburin M, Ferrario R.
    J Med Chem; 1994 Oct 14; 37(21):3588-604. PubMed ID: 7932586
    [Abstract] [Full Text] [Related]

  • 49. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S, Braquet P, Sirois P.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul 14; 37(1):23-4. PubMed ID: 2548218
    [Abstract] [Full Text] [Related]

  • 50. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T, Saito M, Mase T, Hara H, Nagaoka H, Murase K, Tomioka K.
    Lipids; 1991 Dec 14; 26(12):1179-83. PubMed ID: 1668114
    [Abstract] [Full Text] [Related]

  • 51. Influence of thromboxane A2 receptor antagonism on pulmonary vasoconstrictor responses.
    Bradley LM, Stambouly JJ, Czaja JF, Goldstein RE.
    Pediatr Res; 1989 Sep 14; 26(3):175-9. PubMed ID: 2587116
    [Abstract] [Full Text] [Related]

  • 52. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S, Joseph S, Kakkar VV.
    Biochim Biophys Acta; 1987 Mar 11; 927(3):429-36. PubMed ID: 3101746
    [Abstract] [Full Text] [Related]

  • 53. The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
    Stürzebecher S, Witt W.
    Prostaglandins; 1988 Dec 11; 36(6):751-60. PubMed ID: 2469101
    [Abstract] [Full Text] [Related]

  • 54. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig.
    Mihara S, Hara S, Ueda M, Ide M, Fujimoto M.
    Eur J Pharmacol; 1989 Feb 07; 160(3):313-21. PubMed ID: 2523812
    [Abstract] [Full Text] [Related]

  • 55. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
    Bertolino F, Valentin JP, Maffre M, Grelac F, Bessac AM, Maclouf J, Delhon A, Lévy-Toledano S, Patoiseau JF, Colpaert FC.
    Br J Pharmacol; 1995 May 07; 115(1):210-6. PubMed ID: 7647979
    [Abstract] [Full Text] [Related]

  • 56. Role of platelet activating factor in kidney transplant rejection in the rat.
    Butterly DW, Spurney RF, Ruiz P, Pirotzky E, Braquet P, Coffman TM.
    Kidney Int; 1995 Aug 07; 48(2):337-43. PubMed ID: 7564100
    [Abstract] [Full Text] [Related]

  • 57. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F, Whittle BJ, Moncada S.
    Br J Pharmacol; 1994 Dec 07; 113(4):1131-6. PubMed ID: 7889265
    [Abstract] [Full Text] [Related]

  • 58. Endothelial dysfunction augments myogenic arteriolar constriction in hypertension.
    Huang A, Sun D, Koller A.
    Hypertension; 1993 Dec 07; 22(6):913-21. PubMed ID: 8244524
    [Abstract] [Full Text] [Related]

  • 59. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition.
    Pomposiello S, Yang XP, Liu YH, Surakanti M, Rhaleb NE, Sevilla M, Carretero OA.
    J Cardiovasc Pharmacol; 1997 Nov 07; 30(5):599-606. PubMed ID: 9388042
    [Abstract] [Full Text] [Related]

  • 60. The involvement of platelet activating factor in ovulation.
    Abisogun AO, Braquet P, Tsafriri A.
    Science; 1989 Jan 20; 243(4889):381-3. PubMed ID: 2911750
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.